IVIV (no C) [Design Issues]

posted by Dr_Dan  – Germany, 2011-01-18 12:55 (5639 d 11:38 ago) – Posting: # 6442
Views: 5,610

Hi Helmut,
you are right. All I wanted to say is that regarding bioequivalence you can not (only) rely on your dissolution results. At the moment Rahul has a formulation showing comparable dissolution but no bioequivalence. Maybe his dissolution method does not discriminate sufficiently? It is a poorly soluble drug with low bioavailability. These drugs are a nightmare even if you just copy the reference formulation. Once you have a bioequivalent product it is IMHO easier to find reasons for the discrepancy than the other way round.
Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
393 visitors (0 registered, 393 guests [including 29 identified bots]).
Forum time: 01:33 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5